How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis? Fazekas F, Bajenaru O, Berger T, Fabjan T H, Ledinek A H, Jakab G, Komoly S, Kobys T, Kraus J, Kurča E, et al. Front Neurol. 2013; 4:10. Epub 2013 May 01. PMID: 23641231. Abstract CommentRecommendBookmarkWatch